However, AFP expression is heterogeneous—approximately 40% of HCC patients, particularly those with early-stage disease, do not exhibit elevated AFP levels, while some advanced-stage cases may paradoxically show normal levels. This evidence concerns the gene AFP and hepatocellular carcinoma.